Symposium:
263. Carbapenem Resistance in Enterobacteriaceae
Saturday, October 10, 2015: 2:00 PM-3:30 PM
Room: 6--AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the epidemiology of carbapenem resistance (CRE) in the US and world
  • review the available diagnostic strategies to detect carbapnemease-producing enterobacteria
  • define treatment options for CRE infections

Target Audience: Scientists, Researchers, Pharmacists, Microbiologists, Members-in-training, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Investigative ID, Adult ID, Trainee

Moderators:  Cesar Arias, MD, PhD, FIDSA, University of Texas Medical School at Houston and Robert Bonomo, MD, Louis Stokes Cleveland Veterans Affairs Medical Center

Presentations:
2:00 PM
Molecular Epidemiology of CRE
Barry N. Kreiswirth, PhD
3:00 PM
Treatment of CRE
Robert Bonomo, MD

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-203-L01-P

Disclosures:

C. Arias, Pfizer: Grant Investigator and Speaker's Bureau , Consulting fee , Grant recipient and Speaker honorarium
Merck Sharp and Dohme: Grant Investigator and Speaker's Bureau , Grant recipient and Speaker honorarium
Cubist: Grant Investigator and Speaker's Bureau , Grant recipient and Speaker honorarium
Theravance: Grant Investigator and Speaker's Bureau , Grant recipient and Speaker honorarium
Bayer: Consultant , Consulting fee
Actavis: Board Member and Speaker's Bureau , Speaker honorarium
Novartis: Consultant and Speaker's Bureau , Consulting fee and Speaker honorarium

R. Bonomo, Astra Zenaca: Grant Investigator , Research grant
Merck: Grant Investigator , Research grant
Melinta: Grant Investigator , Research grant
Steris: Grant Investigator , Research grant
Wockhardt: Grant Investigator , Research grant
NIH: Grant Investigator , Research grant
VA Merit Review: Grant Investigator , Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.